Sandimmune 250 mg for intravenous infusion, manufactured by Novartis Pharma, contains Cyclosporine. This immunosuppressant, identified by YJ code 3999406A1032, is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants.
Sandimmune 250 mg for intravenous infusion
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
